[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”4.16″ global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_row admin_label=”row” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||” theme_builder_area=”post_content”][et_pb_image src=”https:\/\/nexuswise.com\/my\/wp-content\/uploads\/sites\/3\/2023\/10\/Eczefolia-1.jpg” alt=”eczefolia 1″ title_text=”Eczefolia 1″ align=”center” _builder_version=”4.21.2″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_image][et_pb_text _builder_version=”4.21.2″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”]<\/p>\n
In 2022, approximately 223 million individuals were living with atopic dermatitis with approximately 43 million of them falling within the age group of 1 to 4 years old.<\/p>\n
Eczema, also known as atopic dermatitis, significantly affects around 20% of children and up to 10% of adults, imposing a substantial burden on health and healthcare systems. Atopic dermatitis ranks 15th among non-fatal diseases in disability-adjusted life years, with the highest impact among skin conditions, primarily affecting children.<\/p>\n
[\/et_pb_text][et_pb_image src=”https:\/\/nexuswise.com\/my\/wp-content\/uploads\/sites\/3\/2023\/10\/Eczefolia-2.jpg” alt=”eczefolia 2″ title_text=”Eczefolia 2″ align=”center” _builder_version=”4.21.2″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_image][et_pb_text _builder_version=”4.21.2″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” custom_padding=”||0px|||” sticky_enabled=”0″]<\/p>\n
Eczema, marked by intense itching, skin redness, rash formation, and persistent dryness, profoundly affects comfort and daily life for sufferers.<\/p>\n
[\/et_pb_text][et_pb_image src=”https:\/\/nexuswise.com\/my\/wp-content\/uploads\/sites\/3\/2023\/10\/Eczefolia-Logo-Outlined.png” alt=”eczefolia logo %91outlined%93″ title_text=”Eczefolia Logo %91Outlined%93″ align=”center” _builder_version=”4.21.2″ _module_preset=”default” width=”35%” global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_image][et_pb_image src=”https:\/\/nexuswise.com\/my\/wp-content\/uploads\/sites\/3\/2023\/10\/Eczefolia-3.jpg” alt=”eczefolia 3″ title_text=”Eczefolia 3″ align=”center” _builder_version=”4.21.2″ _module_preset=”default” width=”100%” global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_image][et_pb_text _builder_version=”4.21.2″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”]<\/p>\n
ECZEFOLIA\u2122: Revolutionizing Eczema Care Naturally and Steroid-Free<\/strong><\/span> NutriSeal\u2122 Technology: Elevating Eczema Relief Sustainably and Effectively<\/span><\/strong> [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" In 2022, approximately 223 million individuals were living with atopic dermatitis with approximately 43 million of them falling within the age group of 1 to 4 years old. Eczema, also known as atopic dermatitis, significantly affects around 20% of children and up to 10% of adults, imposing a substantial burden on health and healthcare systems. […]<\/p>\n","protected":false},"author":3,"featured_media":221364,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"none","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"both","_seopress_redirections_param":"","_seopress_redirections_type":301,"_seopress_analysis_target_kw":"","_seopress_news_disabled":"","_seopress_video_disabled":"","_seopress_video":[],"_seopress_pro_schemas_manual":[],"_seopress_pro_rich_snippets_disable_all":"","_seopress_pro_rich_snippets_disable":[],"_seopress_pro_schemas":[],"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[13],"tags":[],"dipi_cpt_category":[],"class_list":["post-221358","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-newsletters"],"_links":{"self":[{"href":"https:\/\/nexuswise.com\/my\/wp-json\/wp\/v2\/posts\/221358","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nexuswise.com\/my\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nexuswise.com\/my\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nexuswise.com\/my\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/nexuswise.com\/my\/wp-json\/wp\/v2\/comments?post=221358"}],"version-history":[{"count":6,"href":"https:\/\/nexuswise.com\/my\/wp-json\/wp\/v2\/posts\/221358\/revisions"}],"predecessor-version":[{"id":221374,"href":"https:\/\/nexuswise.com\/my\/wp-json\/wp\/v2\/posts\/221358\/revisions\/221374"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nexuswise.com\/my\/wp-json\/wp\/v2\/media\/221364"}],"wp:attachment":[{"href":"https:\/\/nexuswise.com\/my\/wp-json\/wp\/v2\/media?parent=221358"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nexuswise.com\/my\/wp-json\/wp\/v2\/categories?post=221358"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nexuswise.com\/my\/wp-json\/wp\/v2\/tags?post=221358"},{"taxonomy":"dipi_cpt_category","embeddable":true,"href":"https:\/\/nexuswise.com\/my\/wp-json\/wp\/v2\/dipi_cpt_category?post=221358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
The world’s first botanical-enriched extract derived from Melicope Ptelefolia, also known as Tenggek Burung, represents a groundbreaking development in the treatment of eczema. This innovative extract offers a safe and effective alternative to traditional treatments, as it is completely steroid-free.<\/p>\n
The adoption of advanced NutriSeal\u2122<\/span> technology ensures that the extract retains the potency and effectiveness of ECZEFOLIA\u2122<\/span>, providing reliable relief for individuals struggling with eczema. This development offers a promising and holistic approach to eczema management, embodying a fusion of nature and advanced science.<\/p>\n